INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 176 filers reported holding INSMED INC in Q2 2019. The put-call ratio across all filers is 1.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $530 | +19.6% | 21 | 0.0% | 0.00% | – |
| Q2 2023 | $443 | +23.7% | 21 | 0.0% | 0.00% | – |
| Q1 2023 | $358 | -14.8% | 21 | 0.0% | 0.00% | – |
| Q4 2022 | $420 | – | 21 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 21 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 21 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 21 | -41.7% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 36 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 36 | -36.8% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 57 | -3.4% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 59 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 59 | +7.3% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 55 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |